Skip to content

Clinical trials

Phase 3 Generalized Anxiety Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Generalized Anxiety Disorder Phase: Phase 3 Clear all

64 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20032
20044
20052
200611
20072
200813
20091
20101
20111
20121
20132
20151
20171
20191
20202
20213
20234
20241
20253
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed39
Recruiting8
Terminated6
Unknown status4
Active, not recruiting3
Not yet recruiting2
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca6
Pfizer6
Otsuka Pharmaceutical Development & Commercialization, Inc.4
Takeda4
Cephalon3
Forest Laboratories3
Beijing Union Pharmaceutical Factory Ltd2
Definium Therapeutics US, Inc.2
Intra-Cellular Therapies, Inc.2
Jazz Pharmaceuticals2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Generalized Anxiety Disorder64
Anxiety Disorders31
Phobia, Social7
Anxiety, Separation4
Mood Disorders3
Obsessive-Compulsive Disorder3
Agoraphobia2
Marijuana Abuse2
Panic Disorder2
Attention Deficit Disorder with Hyperactivity1

Trials

Showing 1 to 25 of 64. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.